US 11413274
Methods and compositions associated with the granulocyte colony-stimulating factor receptor
granted A61KA61K31/404A61K31/41
Quick answer
US patent 11413274 (Methods and compositions associated with the granulocyte colony-stimulating factor receptor) held by Ligand Pharmaceuticals Incorporated expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/404, A61K31/41, A61K31/4152, A61K31/4155